DARLENE HOFFMAN: Open Payments
NPI 1194786913 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 30 payments from 16 companies in 2025. Trend: 2023 $184 · 2024 $182 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $189 |
| AstraZeneca Pharmaceuticals LP | 3 | $174 |
| GlaxoSmithKline, LLC. | 4 | $77 |
| PFIZER INC. | 3 | $63 |
| Exact Sciences Corporation | 2 | $54 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Renalytix AI, Inc. | 2 | $28 |
| ABBVIE INC. | 1 | $24 |
Products named: KISUNLA, BREZTRI, MOUNJARO, PREVNAR 20, The Cologuard Plus Collection Kit, FARXIGA, GEMTESA, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
